JPWO2022149487A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022149487A5
JPWO2022149487A5 JP2022574004A JP2022574004A JPWO2022149487A5 JP WO2022149487 A5 JPWO2022149487 A5 JP WO2022149487A5 JP 2022574004 A JP2022574004 A JP 2022574004A JP 2022574004 A JP2022574004 A JP 2022574004A JP WO2022149487 A5 JPWO2022149487 A5 JP WO2022149487A5
Authority
JP
Japan
Prior art keywords
ion
group
prostate cancer
trimetyl
cyclohexenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022574004A
Other languages
English (en)
Japanese (ja)
Other versions
JP7769179B2 (ja
JPWO2022149487A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/048082 external-priority patent/WO2022149487A1/ja
Publication of JPWO2022149487A1 publication Critical patent/JPWO2022149487A1/ja
Publication of JPWO2022149487A5 publication Critical patent/JPWO2022149487A5/ja
Application granted granted Critical
Publication of JP7769179B2 publication Critical patent/JP7769179B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022574004A 2021-01-07 2021-12-24 前立腺がんの罹患の可能性を検査する方法 Active JP7769179B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021001676 2021-01-07
JP2021001676 2021-01-07
PCT/JP2021/048082 WO2022149487A1 (ja) 2021-01-07 2021-12-24 前立腺がんの罹患の可能性を検査する方法

Publications (3)

Publication Number Publication Date
JPWO2022149487A1 JPWO2022149487A1 (https=) 2022-07-14
JPWO2022149487A5 true JPWO2022149487A5 (https=) 2024-12-09
JP7769179B2 JP7769179B2 (ja) 2025-11-13

Family

ID=82357872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022574004A Active JP7769179B2 (ja) 2021-01-07 2021-12-24 前立腺がんの罹患の可能性を検査する方法

Country Status (7)

Country Link
US (1) US20240085400A1 (https=)
EP (1) EP4276456A4 (https=)
JP (1) JP7769179B2 (https=)
CN (1) CN116783484A (https=)
AU (1) AU2021417970A1 (https=)
TW (1) TW202242412A (https=)
WO (1) WO2022149487A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102893157A (zh) 2009-12-22 2013-01-23 密执安大学评议会 前列腺癌的代谢特征
US20130217647A1 (en) 2010-07-28 2013-08-22 Metabolon, Inc. Biomarkers for Prostate Cancer and Methods Using the Same
US20160025734A1 (en) 2014-07-23 2016-01-28 Children's Medical Center Corporation Use of urinary protein biomarkers to distinguish between neoplastic and non-neoplastic disease of the prostate
JP2017203649A (ja) 2016-05-09 2017-11-16 国立大学法人大阪大学 前立腺がん判定方法
CN108344830B (zh) * 2017-01-22 2020-10-16 中国科学院大连化学物理研究所 用于诊断前列腺癌的尿样组合标志物及检测试剂盒
US10908162B2 (en) * 2017-10-27 2021-02-02 The Board Of Regents Of The University Of Texas System Methods related to volatile compounds in genitourinary cancers

Similar Documents

Publication Publication Date Title
Gao et al. Proteomic analysis of acetaminophen‐induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury
Monleau et al. Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells
JP2018509934A5 (https=)
JP2006509186A5 (https=)
Hewawasam et al. Estimation of the volume of blood in a small disc punched from a dried blood spot card
JP2008533471A5 (https=)
Turner et al. Detection of allantoin in clinical samples using hydrophilic liquid chromatography with stable isotope dilution negative ion tandem mass spectrometry
JP2020514689A5 (https=)
US20180299448A1 (en) Colorectal cancer screening method
CN109632780B (zh) 一种检测atp的比色方法及试剂盒
CN103630678A (zh) 男性不育的生物标志物及其应用
AU8474701A (en) Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
Pourkarim et al. A simple colorimetric method for determination of ethanol in exhaled breath condensate
Whiteaker et al. Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage
Miękus et al. Non-invasive screening for neuroendocrine tumors—Biogenic amines as neoplasm biomarkers and the potential improvement of “gold standards”
Boogaard et al. Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1, 3-butadiene: a basis for 1, 3-butadiene cancer risk assessment.
JP2019510974A5 (https=)
Oberpenning et al. Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer?
Yuan et al. Liver fibrosis associated with potential vinyl chloride and ethylene dichloride exposure from the petrochemical industry
JPWO2022149487A5 (https=)
Natarajan et al. Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy
JP2022541169A5 (https=)
JP2007248395A5 (https=)
Xiang et al. Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection.
Natarajan et al. Flow injection ionization-tandem mass spectrometry-based estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy